New research published in Radiology on Hologic’s 3DQuorum® imaging technology demonstrates AI’s potential to streamline radiologists’ workflows while upholding high sensitivity in detecting breast cancer.

In a study led by Dr. Manisha Bahl, M.D., MPH, FSBI, Associate Medical Director of Quality at Mass General Brigham and Associate Professor of Radiology at Harvard Medical School, researchers at Massachusetts General Hospital evaluated Hologic's 3DQuorum imaging technology.

Based on more than 119,000 screening mammography exams, the retrospective study compared cancer detection rates before and after adopting 3DQuorum, which uses AI to reduce the number of 3D imaging “slices” radiologists need to review without compromising image quality, sensitivity or accuracy.^1,2 In the simplest terms, the technology is comparable to condensing a 60-page book into a 10-page summary that retains all relevant information and highlights key findings.

The study found no significant difference in cancer detection rates after implementation of 3DQuorum. With ongoing radiologist shortages, these results suggest the technology’s potential to streamline radiologists’ workflows and save valuable time while maintaining high effectiveness in detecting cancers.

“AI holds boundless potential in healthcare that we are only beginning to tap into, with a wide range of applications that can improve patient care,” said Dr. Bahl. “In breast cancer screening, technologies like 3DQuorum help radiologists work more efficiently while still delivering the same high-quality care to every woman. By streamlining the review process, AI allows us to focus our attention where it matters most: finding cancers early and supporting each patient with confidence.”